Unlikely to cause harm — often a labeling or packaging issue.
Failed Tablet/Capsule Specifications: Sandoz is recalling one lot of Hydroxychloroquine Sulfate Tablets, USP, 200mg, due to illegibility of the logo on some tablets.
| Distributed by / for | Sandoz Incorporated |
| NDC | 0781-1407-01 |
| Full product label | Hydroxychloroquine Sulfate Tablets, USP, 200 mg, Rx Only, 100 Tablets per bottle, Sandoz Inc., Princeton NJ, 08540, NDC 0781-1407-01. |
| Recalling firm | Sandoz Incorporated |
| Distribution | Nationwide |
| Quantity | 25,830 bottles |
| Recall initiated | 2013-09-25 |
| Report date | 2013-10-16 |
| Recall completed | 2014-07-16 |
| Recall number | D-66373-001 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | Broomfield CO United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗